ZYXI (Zynex Inc) Short-Term Debt to Capital
The share price history of Zynex, Inc. (ZYXI) reflects the dynamics of a company promoting a safe opioid alternative for chronic pain management through the direct sale of electrical stimulation devices. The current metric stands at 0.00. The business relies on a closed-loop sales cycle for NexWave and ancillary materials, while sustainable growth is driven by a strong team of engineers and regulatory experts, supplemented by targeted specialist hiring.
zynex.com - analytical breakdowns and key metrics (ZYXI)
Liquidity control is critical for Zynex, Inc. (ZYXI), which is currently at the peak of development costs for non-invasive monitors and pain management systems. The current value of 0.00 reflects the ratio of liabilities maturing within one year to equity, while the trend of short-term liabilities relative to equity allows for an assessment of working capital deficit risks in preparation for FDA releases.